Replay and Transcript: Demant - Barclays Conversations with the C-Suite in European Healthcare 2026

Research evidence excerpt

Replay and Transcript: Demant - Barclays Conversations with the C-Suite in European Healthcare 2026

al debt research reports to various issuers, media, regulatory and academic

organisations for their own internal informational news gathering, regulatory or academic purposes and not for the purpose of making investment

decisions regarding any debt securities. Media organisations are prohibited from re-publishing any opinion or recommendation concerning a debt

issuer or debt security contained in any Barclays institutional debt research report. Any such recipients that do not want to continue receiving Barclays

institutional debt research reports should contact debtresearch@barclays.com. Unless clients have agreed to receive “institutional debt research

reports” as required by US FINRA Rule 2242, they will not receive any such reports that may be co-authored by non-debt research analysts. Eligible

clients may get access to such cross asset reports by contacting debtresearch@barclays.com. Barclays will not treat unauthorized recipients of this

report as its clients and accepts no liability for use by them of the contents which may not be suitable for their personal use. Prices shown are

indicative and Barclays is not offering to buy or sell or soliciting offers to buy or sell any financial instrument.

Without limiting any of the foregoing and to the extent permitted by law, in no event shall Barclays, nor any affiliate, nor any of their respective officers,

directors, partners, or employees have any liability for (a) any special, punitive, indirect, or consequential damages; or (b) any lost profits, lost revenue,

loss of anticipated savings or loss of opportunity or other financial loss, even if notified of the possibility of such damages, arising from any use of this